Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients

BACKGROUND: Pathological complete response (pCR) is the ultimate response in breast cancer patients treated with neoadjuvant chemotherapy (NCT). It might be a surrogate outcome for disease-free survival (DFS) and overall survival (OS). We studied the effect of clinical tumor stage (cT-stage) on tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Goorts, Briete, van Nijnatten, Thiemo J. A., de Munck, Linda, Moossdorff, Martine, Heuts, Esther M., de Boer, Maaike, Lobbes, Marc B. I., Smidt, Marjolein L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387027/
https://www.ncbi.nlm.nih.gov/pubmed/28205044
http://dx.doi.org/10.1007/s10549-017-4155-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387027/
https://www.ncbi.nlm.nih.gov/pubmed/28205044
http://dx.doi.org/10.1007/s10549-017-4155-2

Ejemplares similares